Clinical and prognostic significance of Parathyroid Hormone-Related Protein in breast cancer: a systematic review and meta-analyses of observational studies in women.
Endocrine-Related Cancer · 2026
DOI: 10.1530/erc-25-0324 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Endocrine-Related Cancer, 2026. Verfasst von Alisson Clemenceau und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Parathyroid Hormone-Related Protein, Breast Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Parathyroid hormone related protein (PTHrP) is produced by normal breast epithelial cells and is a cause of hypercalcemia in breast and other cancers. However, there are conflicting data regarding its role(s) in breast cancer biology. This study aimed to clarify PTHrP’s potential function(s) in breast cancer by systematically examining its association with tumor characteristics, patient outcomes and hypercalcemia in women.
Methods
We designed a pre-determined strategy based on PRISMA 2020 guidelines. Seven databases were interrogated to identify studies of women with breast cancer reporting associations between tumor or circulating PTHrP levels and prognostic factors, calcium levels, relapse and survival. The ROBINS-E tool was used to examine the risk of bias. Quantitative syntheses of outcomes were performed by drawing forest-plots of individual studies and pooling estimates.
Results
Forty-five studies met our eligibility criteria. We found that PTHrP is likely associated with positive progesterone receptor status, the presence of microcalcifications and lymph node invasion, but not with tumor type or grade. Most studies interrogating the association between PTHrP expression and breast cancer prognosis or hypercalcemia were at very high risk of bias. Despite this, our results suggest associations between PTHrP and patient survival, the presence of bone metastases and the diagnosis of hypercalcemia of malignancy.
Conclusions
These meta-analyses underscore the need for robust multivariate analyses in women to rigorously re-evaluate the role of PTHrP in breast cancer. This is important since the gene coding for PTHrP ( PTHLH ) has been consistently identified as a breast cancer susceptibility locus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
- CHU de Québec Research Center-Laval University, Quebec City, Quebec, Canada.
- Department of Molecular Medicine, Cancer Research Center, Faculty of Medicine, Laval University, Quebec City, Quebec, Canada.
- Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, Connecticut, USA.
- Department of Social and Preventive Medicine, Cancer Research Center, Faculty of Medicine, Laval University, Quebec City, Quebec, Canada.
- Center for Breast Diseases, Saint-Sacrement Hospital, Quebec City, Quebec, Canada.
ORCID-Profile: Alisson Clemenceau
Zitieren
APA
Clemenceau, A., Bherer, J., Grimshaw, A., Durocher, F., Diorio, C., & Wysolmerski, J. J. (2026). Clinical and prognostic significance of Parathyroid Hormone-Related Protein in breast cancer: a systematic review and meta-analyses of observational studies in women. Endocrine-Related Cancer. https://doi.org/10.1530/erc-25-0324
Vancouver
Clemenceau A, Bherer J, Grimshaw A, Durocher F, Diorio C, Wysolmerski JJ. Clinical and prognostic significance of Parathyroid Hormone-Related Protein in breast cancer: a systematic review and meta-analyses of observational studies in women. Endocrine-Related Cancer. 2026. doi:10.1530/erc-25-0324
BibTeX
@article{Clemenceau2026,
author = {Clemenceau, Alisson and Bherer, Juliette and Grimshaw, Alyssa and Durocher, Francine and Diorio, Caroline and Wysolmerski, John J},
title = {Clinical and prognostic significance of Parathyroid Hormone-Related Protein in breast cancer: a systematic review and meta-analyses of observational studies in women},
journal = {Endocrine-Related Cancer},
year = {2026},
doi = {10.1530/erc-25-0324}
}
EUVIMED